Back to Directory
TeslaDiagnostiX
Founded 2022
Lab-on-PCB biosensors for non-invasive point-of-care diagnostics
TeslaDiagnostiX develops miniaturised electrochemical diagnostic systems using lab-on-printed-circuit-board technology for biological sample testing.
Its lead programme is a quantitative saliva glucose assay intended to provide a non-invasive alternative to blood-based measurement. The device combines disposable PCB sensor strips, amperometric detection and pH compensation to measure low glucose concentrations. The company is also developing lab-on-chip platforms for broader point-of-care testing and potential industrial biosensing applications.